Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48h of total sleep deprivation

被引:18
|
作者
Hansen, Devon A. [1 ,2 ]
Ramakrishnan, Sridhar [3 ]
Satterfield, Brieann C. [1 ,2 ,4 ]
Wesensten, Nancy J. [5 ]
Layton, Matthew E. [1 ,2 ]
Reifman, Jaques [3 ]
Van Dongen, Hans P. A. [1 ,2 ]
机构
[1] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA 99202 USA
[2] Washington State Univ, Elson S Floyd Coll Med, Spokane, WA 99202 USA
[3] US Army Med Res & Mat Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res, Frederick, MD USA
[4] Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ USA
[5] FAA, Air Traff Org, Washington, DC USA
关键词
Caffeine gum; Cognitive performance; Within-subject design; Dose response; Sleep loss; COGNITIVE PERFORMANCE; PSYCHOMOTOR VIGILANCE; MAINTAINS VIGILANCE; MODEL; FATIGUE; NIGHT; IMPAIRMENT; OPERATIONS; ALERTNESS;
D O I
10.1007/s00213-018-5140-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
RationaleCaffeine is widely used as a countermeasure against neurobehavioral impairment during sleep deprivation. However, little is known about the pharmacodynamic profile of caffeine administered repeatedly during total sleep deprivation.ObjectivesTo investigate the effects of repeated caffeine dosing on neurobehavioral performance during sleep deprivation, we conducted a laboratory-based, randomized, double-blind, placebo-controlled, crossover, multi-dose study of repeated caffeine administration during 48h of sleep deprivation. Twelve healthy adults (mean age 27.4years, six women) completed an 18-consecutive-day in-laboratory study consisting of three 48h total sleep deprivation periods separated by 3-day recovery periods. During each sleep deprivation period, subjects were awakened at 07:00 and administered caffeine gum (0, 200, or 300mg) at 6, 18, 30, and 42h of wakefulness. The Psychomotor Vigilance Test and Karolinska Sleepiness Scale were administered every 2h.ResultsThe 200 and 300mg doses of caffeine mitigated neurobehavioral impairment across the sleep deprivation period, approaching two-fold performance improvements relative to placebo immediately after the nighttime gum administrations. No substantive differences were noted between the 200 mgand 300mg caffeine doses, and adverse effects were minimal.ConclusionsThe neurobehavioral effects of repeated caffeine dosing during sleep deprivation were most evident during the circadian alertness trough (i.e., at night). The difference between the 200mg and 300mg doses, in terms of the mitigation of performance impairment, was small. Neither caffeine dose fully restored performance to well-rested levels. These findings inform the development of biomathematical models that more accurately account for the time of day and sleep pressure-dependent effects of caffeine on neurobehavioral performance during sleep loss.
引用
收藏
页码:1313 / 1322
页数:10
相关论文
共 50 条
  • [1] Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48 h of total sleep deprivation
    Devon A. Hansen
    Sridhar Ramakrishnan
    Brieann C. Satterfield
    Nancy J. Wesensten
    Matthew E. Layton
    Jaques Reifman
    Hans P. A. Van Dongen
    Psychopharmacology, 2019, 236 : 1313 - 1322
  • [2] TNFαG308A genotype, resilience to sleep deprivation, and the effect of caffeine on psychomotor vigilance performance in a randomized, double-blind, placebo-controlled, crossover study
    Skeiky, Lillian
    Brager, Allison J.
    Satterfield, Brieann C.
    Petrovick, Martha
    Balkin, Thomas J.
    Capaldi, Vincent F.
    Ratcliffe, Ruthie H.
    Van Dongen, Hans P. A.
    Hansen, Devon A.
    CHRONOBIOLOGY INTERNATIONAL, 2020, 37 (9-10) : 1461 - 1464
  • [3] The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study
    Ahmed, Mansoor
    Aamir, Rozina
    Jishi, Zahra
    Scharf, Martin B.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2016, 12 (01): : 79 - 86
  • [4] Effects of caffeine ingestion on dynamic visual acuity: a placebo-controlled, double-blind, balanced-crossover study in low caffeine consumers
    Redondo, Beatriz
    Jimenez, Raimundo
    Molina, Ruben
    Dalton, Kristine
    Vera, Jesus
    PSYCHOPHARMACOLOGY, 2021, 238 (12) : 3391 - 3398
  • [5] Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study
    Casini, ML
    Marelli, G
    Papaleo, E
    Ferrari, A
    D'Ambrosio, F
    Unfer, V
    FERTILITY AND STERILITY, 2006, 85 (04) : 972 - 978
  • [6] Lorazepam Effects on Word Memory Test Performance: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
    Loring, David W.
    Marino, Susan E.
    Drane, Daniel L.
    Parfitt, David
    Finney, Glen R.
    Meador, Kimford J.
    CLINICAL NEUROPSYCHOLOGIST, 2011, 25 (05) : 799 - 811
  • [7] Caffeine improves endurance in 75-yr-old citizens: a randomized, double-blind, placebo-controlled, crossover study
    Norager, CB
    Jensen, MB
    Madsen, MR
    Laurberg, S
    JOURNAL OF APPLIED PHYSIOLOGY, 2005, 99 (06) : 2302 - 2306
  • [8] Effect of chlorogenic acids on fatigue and sleep in healthy males: A randomized, double-blind, placebo-controlled, crossover study
    Ochiai, Ryuji
    Tomonobu, Kazuichi
    Ikushima, Ippei
    FOOD SCIENCE & NUTRITION, 2018, 6 (08): : 2530 - 2536
  • [9] The effects of palatinose on attention and cerebral blood flow in healthy adults: A randomized double-blind placebo-controlled crossover study
    Yamamoto, Natsumi
    Sakazaki, Miki
    Nagai, Yukie
    Shoji, Masanori
    Kawashima, Ryuta
    BRAIN RESEARCH, 2023, 1820
  • [10] Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study
    Bested, Kirsten
    Jensen, Lotte M.
    Andresen, Trine
    Tarp, Grete
    Skovbjerg, Louise
    Johansen, Torben S. D.
    Schmedes, Anne V.
    Storgaard, Ida K.
    Madsen, Jonna S.
    Werner, Mads U.
    Bendiksen, Anette
    PAIN REPORTS, 2023, 8 (04) : E1080